原薬工業会とはごあいさつ

Medicinal drugs have been obviously related with global health promotion and life being. In this situation, Active Pharmaceutical Ingredients (APIs) play a key role in efficacy and safety of medicinal drugs.
We, members of JAPIA have been producing safe and trustworthy APIs by complying with Good Manufacturing Practice (GMP) and various international rules. To provide better APIs, our members keep discussing and supporting each other not only to maintain but to further improve our reliability and current technologies.
JAPIA organizes some committees dealing with technical matters including GMP committee and Regulatory committee. In the GMP committee, the members are discussing to develop and share operational solutions for GMP matters to promote reliable production in each company. In the Regulatory committee, the members are studying the various regulations related with API production and address several legal issues when they come up.
Furthermore, we contribute to the development of the Japanese pharmaceutical industry by promoting close cooperation with the relevant industrial organizations such as the Federation of Pharmaceutical Manufacturers’ Association of Japan (FPMAJ) and the Japan Pharmaceutical Manufacturers Association (JPMA).
I am sure that the strength of Japanese API industry is ‘reliability’ backed up by our integrity and technologies. We believe the pharmaceutical industries all over the world are willing to accept our safe and trustworthy API.
We hereby promise to contribute to the sustainable growth of our members and entire pharmaceutical industry through providing APIs in the future as well.

Yoshihiro Tomita
President
Japan Active Pharmaceutical Ingredient Association (JAPIA)